DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

46.38 -0.29 (-0.62%)

REAL-TIME: Last trade at

Extended Hours: $46.89 $0.51 (1.11%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

NBIX $46.38 -0.62%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.71
Previous Close $46.67
Daily Range $46.24 - $48.14
52-Week Range $15.10 - $56.18
Market Cap $4.0B
P/E Ratio -61.41
Dividend (Yield) $0.00 (0.0%)
Volume 890,846
Average Daily Volume 727,712
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

NBIX's Top Competitors

NBIX $46.38 (-0.62%)
Current stock: NBIX
AMGN $151.78 (-2.64%)
Current stock: AMGN
GILD $105.07 (-2.51%)
Current stock: GILD
BIIB $297.30 (-2.10%)
Current stock: BIIB